Oncotarget PRDX1 Identified as Key to Chemotherapy Resistance in Cancer Cells targeting PRDX1 should sensitize tumours to DNA-damaging agents."Scientists have uncovered a promising new strategy... read more July 14, 2025
Oncotarget Behind the Study: Potential Therapeutic Target in Breast Cancer Cells Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study... read more May 17, 2021